To analyse whether diffusion-weighted imaging (DWI) predicts Gleason score (GS) upgrading in biopsy-proven low grade prostate cancer (PCa).
Introduction
Because a Gleason score (GS) threshold ≤6 is one of clinical determinants of whether or not active surveillance is suitable for patients with prostate cancer (PCa), accurate prediction of final GS is important to avoid underestimation of the patient risk [1] ; however, 20-60% of patients PCa with biopsy-proven GS ≤6 are upgraded to GS ≥7 postoperatively [2] [3] [4] [5] [6] .
Researchers have investigated preoperative clinical findings that may predict GS upgrading. In some studies, multivariate analysis showed that serum PSA level [3, 4, [6] [7] [8] , greatest percentage of cancer in a biopsy core [4, 6, 7] , percentage of positive cores [3, 4, 7] and clinical stage [7] are related to GS upgrading; however, there are discrepancies among these studies with regard to the variables used for prediction and the biopsy schemes used (i.e. 6, 8 or 12 cores). The number of TRUS-guided biopsy cores may also influence the accuracy of GS prediction [9, 10] .
Nowadays, it is generally accepted that the apparent diffusion coefficient (ADC) derived from diffusion-weighted imaging (DWI) in PCa has a negative correlation with GS [11] [12] [13] . Accordingly, DWI may have the potential to predict GS upgrading in biopsy-proven low grade PCa [14] . In most previous studies, however, cancer ADC was measured by unblinded radiologists who were aware of the lesion location of the surgical specimen, while in daily practice, radiologists usually interpret prostate MRI without surgical information because it is a preoperative process. More validation is therefore required to confirm the clinical utility of DWI in predicting GS upgrading by blinded readers. To this end, we analysed whether or not DWI variables, measured by blinded readers, could predict GS upgrading of PCa with biopsyproven GS ≤6.
Patients and Methods

Study Subjects
Our institutional review board approved the present retrospective study, and the requirement for informed consent was waived. Between January 2010 and December 2012, a consecutive series of 1 483 patients was identified using the search terms 'prostate MRI' and 'radical prostatectomy'. Various MRI platforms were used for prostate imaging in these patients during the study period. Because there can be significant variability in ADC values with different MRI platforms, we selected a single 3T MRI platform that was used to examine the largest number of patients with PCa [15, 16] . A total of 910 patients who were examined with the same MRI platform (Intera Archieva; Philips Medical Systems, Eindhoven, the Netherlands) were selected for inclusion in the study. Of these, 778 were excluded for the following reasons: absence of full 12-core biopsy data (n = 590) as fewer biopsy cores may decrease the accuracy of the GS [9, 10] ; biopsy GS > 6 PCa (n = 185); poor image quality of the ADC map (n = 2); and absence of the ADC map (n = 1; Fig. 1 ). A total of 132 patients with biopsy GS ≤6 PCa were finally included in the analysis.
MRI Protocol
T1-weighted, T2-weighted, dynamic contrast-enhanced (DCE) imaging and DWI were used in the MRI protocol (Table 1) . A single type of 3T MRI (Intera Archieva; Philips Medical Systems) with a phased-array body coil was used. The MRI was performed 3-5 weeks after TRUS-guided biopsy and before surgery. Before MRI examination, 20 mg of butyl scopolamine (Buscopan; Boehringer Ingelheim, Ingelheim am Rhein, Germany) was injected i.m. to suppress bowel peristalsis [17] .
From the DWI data, an ADC map was generated using the following equation:
where b indicates the b value and S(0) and S(b) are the signal intensities of images with b values = 0 and 1 000 s/mm 2 .
Clinical and Pathological Variables
An experienced pathologist (blinded, >15 years of experience in PCa) examined the biopsy cores and surgical specimens of the prostate gland. The findings from the whole-mount stepsection of the resected prostate gland were used as the standard of reference for surgical GS. 
Diffusion-Weighted Imaging Variables
The DWI data were transferred to the workstation using manufacturer-supplied software (Philips Healthcare). Two independent genitourinary radiologists (both blinded and with 9 and 4 years' experience in prostate MRI, respectively), who were unaware of the clinical and pathological results, interpreted the MRI.
For ADC measurement, two types of ellipsoid interest (regions of interest [ROIs]) were drawn within an MRIsuspected cancerous lesion to obtain both the minimum ADC (ADC min ) and mean ADC (ADC mean ) values as follows: ADC min was measured at the focal area showing lowest ADC in a MRI-suspected lesion, with a small ROI of 5-10 mm 2 , and ADC mean was measured with an ROI covering more than half of a MRI-suspected lesion. The MRI-suspected cancerous lesion was defined as a focal area showing homogeneous low T2 signal intensity, low ADC and earlier enhancement, compared with adjacent prostatic tissues [17] [18] [19] . The areas of T1 hyperintensity in the peripheral zone suggestive of post-biopsy haemorrhage or well-circumscribed nodules with T2 hypointense capsule-like margin in the central gland suggestive of benign hyperplastic nodules were excluded from the measurement [20, 21] . When multiple cancer foci were suspected in a particular patient, the cancer ADC was measured only for a lesion showing a homogeneous and lower ADC because a cancer with lower ADC is likely to be histologically more aggressive [22] [23] [24] . When a MRIsuspected lesion was too small to draw different sizes for the ROI, ADC mean was considered to be equal to the ADC min that was measured with a single ROI of 5-10 mm 
Statistical Analysis
The Mann-Whitney test was used to compare the nonnormally distributed variables PSA, greatest percentage of cancer in a biopsy core, percentage of positive cores, and ADC min and ADC mean values between the group with GS upgrading and the group without. Both univariate and multivariate analyses using logistic regression were performed to assess whether or not the preoperative clinical and DWI variables were associated with GS upgrading. Because of a strong correlation between ADC min and ADC mean (q = 0.961-0.969 [Spearman's rank correlation] in both readers; P < 0.001), multiple logistic regression was separately analysed using one of the two ADCs.
Receiver-operating characteristic curve analysis was performed to estimate the area under the curve (AUC) for preoperative clinical and DWI variables for predicting GS upgrading. Using the Youden-selected thresholds, both sensitivity and specificity of the variables for the prediction of GS upgrading were investigated. The AUCs of ADC min and ADC mean were compared using z statistics. The statistical analyses were performed using MEDCALC (version 13.0; MedCalc Software, Mariakerke, Belgium). 
Results
Comparison of Upgrading and Non-Upgrading Groups
The rate of GS upgrading was 46.1% (61/132). In the 61 patients with GS upgrading, the majority of upgrading was from GS 6 to GS 7 (95.1%, 58/61), while only three of 61 patients (4.9%) had surgically proven GS of 8 or 9 ( /s for reader 2; P < 0.05 [ Fig. 2]) . Preoperative clinical variables (PSA, greatest percentage of cancer in a biopsy core and percentage of positive cores), however, were not significantly different between the two groups (P > 0.05 [ Table 3 ]).
Univariate and Multivariate Analyses
In univariate analysis, both ADC min (odds ratio [OR] 0.011; P < 0.001) and ADC mean (OR 0.030; P < 0.001) were persistently significant for predicting GS upgrading (P < , ADC mean and ADC min were significantly lower in patients with GS upgrading than in patients without GS upgrading, respectively (P < 0.001). were also significant for predicting GS upgrading (P < 0.05), while none of the clinical variables was significant (P > 0.05; Figs 3,4). OR, odds ratio; ADC, apparent diffusion coefficient. PSA, Greatest percentage of cancer in a biopsy core and positive core data derived from the univariate analysis were same between two readers. Because of the strong correlation between ADC min and ADC mean , multiple logistic regression was separately analysed using one of two ADCs. PSA, greatest percentage of cancer in a core, and percentage of positive cores were insignificant in the multivariate analysis. 
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Receiver-Operating Curve Analysis
The AUCs of the clinical variables were 0.503-0.593 for predicting GS upgrading and the AUCs for the DWI variables were 0.711-0.760 (Table 5 ). For predicting GS upgrading, the Youden-selected thresholds were ADC min ≤0.77 and ADC mean ≤0.84 mm 2 /s for reader 1, and ADC min ≤0.89 and ADC mean ≤0.91 mm 2 /s for reader 2. The sensitivity and specificity were 52.5 and 88.7% with ADC min , and 49.2 and 84.5% with ADC mean for reader 1, while they were 75.4 and 67.6% with ADC min , and 60.7 and 76.1% with ADC mean for reader 2, respectively, by using the ADC thresholds.
In the comparison of DWI variables, the AUC of ADC min was significantly greater than that of ADC mean for predicting GS upgrading for both readers (reader 1: AUC 0.760 vs 0.711, P < 0.001; reader 2: AUC 0.752 vs 0.714; P = 0.003 [ Fig. 5]) . 
Inter-reader Agreement
The inter-reader agreement was excellent with regard to ADC mean (CCC 0.803; 95% CI 0.734-0.856), and good with regard to ADC min (CCC 0.764; 95% CI 0.686-0.825).
Relationship Between Cancer Apparent Diffusion Coefficient and Surgical Gleason Score
Using Spearman's correlation, the ADC min showed moderate inverse correlation (reader 1: q = À0.465; reader 2 q = À0.450; P < 0.001), while ADC mean had a weak inverse correlation (reader 1: q = À0.383; reader 2: q = À0.389; P < 0.001) with surgically proven GS of PCa (Fig. 6) .
Discussion
In the present study, the two types of ADC were independently predictive of GS upgrading of PCa with biopsy-proven GS ≤6. In addition, the ADCs were inversely correlated with the surgical GS of PCa. Hence, the present study validated the clinical utility of ADC in predicting GS upgrading in PCa [14] , according to the previous reports in terms of the relationship between cancer ADC and GS [11] [12] [13] . The use of preoperative DWI in the prediction of GS upgrading may therefore be applicable on a per-patient basis in daily practice.
Although the Gleason grading system has a prognostic impact in patients with PCa [25] , there were limitations in accurate prediction of the final GS with the systemic biopsy because a hallmark of PCa is histological heterogeneity [26] . Accordingly, TRUS-guided systemic biopsy may not be guaranteed to sample the most aggressive part of the PCa [27] ; however, preoperative assessment of MRI could help localize PCa and detect the most significant cancerous area [28, 29] .
Reportedly, the ADC in cancer is inversely correlated with the cancer cellularity, which enables the histological aggressiveness of PCa to be predicted non-invasively [11] [12] [13] . In the present study, two types of cancer ADCs (ADC min and ADC mean ) were measured under the assumption that ADC min may be measured in a focal area of the highest cancer cellularity, suggestive of the most aggressive region, and ADC mean may reflect the overall histological status of a cancerous region. In a previous study, Spearman's correlation analysis showed significant correlation between the minimum 25th percentile ADC of peripheral zone cancers and the cancer aggressiveness (q = À0.63) [30] . In addition, in brain [31] , liver [32] and breast cancers [33] , the application of small ROIs in the area of lowest ADC was reported to be helpful for estimating pathological or clinical outcomes. In the present study, ADC min had better correlation with final GS (q = À0.465 to À0.450) compared with ADC mean (q = À0.389 to À0.383), which might be related to the better performance of ADC min in predicting GS upgrading; however, further radiological-pathological correlation is required to confirm it.
Between two readers, there was a slight difference in the Youden-selected threshold value of cancer ADC for the prediction of GS upgrading (ADC min 0.77 vs 0.89 mm 2 /s; ADC mean 0.84 vs 0.91 mm 2 /s) although good or excellent inter-reader agreement was shown in measuring ADCs. Previous data have consistently suggested that the range of cancer ADCs is overlapped between different GSs such as 6 and 7 [34, 35] . Hence, the prediction of GS upgrading could sometimes be difficult when MRI-suspected PCa shows a borderline range of ADC such as 0.8-1.0 mm In the present study, none of the clinical variables was significantly predictive of GS upgrading. According to previous studies [3, 4, [6] [7] [8] , serum PSA level was related to GS upgrading of the low grade PCa although conflicting data have also been reported [2, 37, 38] . In the present study, the median serum PSA level was 8.3 ng/dL in the upgrading group and 6.9 ng/dL in the non-upgrading group (P = 0.065). This might be related to the relatively small study population (n = 132). In terms of the systemic biopsy variables (greatest percentage of cancer in a biopsy core or percentage of positive cores), controversies also remain [3, 4] . Further prospective validations in a large population are warranted.
The present study had some limitations. First, the cancer ADC was analysed at a patient level. Approximately 20% of small, low grade PCa may not be seen on MRI [23] , so benign lesions, such as focal inflammation [39] or stromal hyperplasia [40] , might be misdiagnosed as cancers on MRI; however, we applied the well-established MRI criteria for PCa, which consist of: T2-hypointensity; diffusion restriction; and focal early enhancement. Additionally, the areas of T1 Relationship between cancer apparent diffusion coefficient (ADC) and surgically proven Gleason score (GS). The subjects were classified into GS < 7, GS = 7, and GS > 7 subgroups. For reader 1 (A and B) and reader 2 (C and D), ADC mean showed weak inverse correlation (q = À0.389 to À0.383; P < 0.001) with surgically proven GS of the prostate cancers. The ADC min showed moderate inverse correlation (q = À0.465 to À0.450; P < 0.001).
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© 2016 The Authors BJU International © 2016 BJU International hyperintensity in the peripheral zone suggestive of post-biopsy haemorrhage or well-circumscribed nodules with a T2 hypointense capsule-like margin in the central gland suggestive of BPH nodules were excluded to minimize ADC measurement for the false lesions. Using the criteria, the ADC of MRI-suspected cancer was correlated with GS for two observers consistently; these findings were concordant with previous reports. Nevertheless, further prospective studies using lesion-based or sector-based analysis are required. Second, the study was performed retrospectively, so there was potential selection bias; however, we tried to include consecutive patients who had all of the preoperative clinical variables, prostate MRI and surgical confirmation during the study period. Third, we used a single MRI platform because significant variability in ADC values may exist according to different MRI platforms; however, further investigations using various MRI scanners are required to test the transferability of ADC application in the prediction of GS upgrading.
In conclusion, DWI may help predict GS upgrading in PCa with biopsy-proven GS ≤6. ADC min seems to perform better than ADC mean . The present findings require further prospective validation.
